NCT05022043View on ClinicalTrials.gov

Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

June 15, 2021

Conditions
Neonatal Sepsis
Interventions
DIAGNOSTIC_TEST

Serum Presepsin

Estimation of Serum Presepsin at time of admission

Trial Locations (1)

Unknown

Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05022043 - Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis | Biotech Hunter | Biotech Hunter